Mortality in early inflammatory polyarthritis: Cardiovascular mortality is increased in seropositive patients

Arthritis and Rheumatism

Volumn 46, Issue 8, 2002, Pages 2010-2019

  Goodson, Nicola J ^a   Wiles, Nicola J ^a   Lunt, Mark ^a   Barrett, Elizabeth M ^b   Silman, Alan J ^a   Symmons, Deborah P M ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MICHAEL'S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; CALCULATION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH SERVICE; POLYARTHRITIS; PRIORITY JOURNAL; REGISTER; RHEUMATOID ARTHRITIS; SERODIAGNOSIS; UNITED KINGDOM;

ADULT; AGED; ARTHRITIS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RHEUMATOID FACTOR; SURVIVAL RATE;

EID: 0036675108     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10419     Document Type: Article

References (43)

1. The mortality of rheumatoid arthritis
2. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden
3. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis
4. Longterm mortality outcomes in patients with rheumatoid arthritis: Early presenters continue to do well
5. Mortality and survival in rheumatoid arthritis: A 25 year study of 100 patients
6. Cause of death in rheumatoid arthritis
7. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years
8. Cardiovascular mortality in women with rheumatoid arthritis
9. Survival, prognosis, and causes of death in rheumatoid arthritis
10. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: A study of incidence, prevalence and mortality
11. Mortality in rheumatoid arthritis patients with disease onset in the 1980s
12. Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992
13. No increased mortality in patients with rheumatoid arthritis: Up to 10 years of follow up from disease onset
14. Factors predicting a poor life prognosis in rheumatoid arthritis: An eight year prospective study
15. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate
16. Novel risk factors for atherosclerosis
17. A tale of two diseases: Atherosclerosis and rheumatoid arthritis
18. The incidence of rheumatoid arthritis in the United Kingdom: Results from the Norfolk Arthritis Register
19. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
20. Estimating the incidence of rheumatoid arthritis: Trying to hit a moving target?
21. Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis
22. Regression models and life tables (with discussions)
23. Rheumatoid factor, chronic arthritis and mortality
24. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg study 1984 to 1992
25. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case control study
26. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
27. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
28. Fibrinogen as a cardiovascular risk factor: A meta-analysis
29. Dyslipidaemia and rheumatoid arthritis
30. Homocysteine and risk of cardiovascular disease among postmenopausal women
31. Abnormal homocysteine metabolism in rheumatoid arthritis
32. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease
33. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis
34. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: A retrospective cohort study from disease onset
35. Risk of cardiovascular events associated with selective COX-2 inhibitors
36. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis
37. High Incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors
38. Risk factors for cardiovascular disease in Chilean patients with rheumatoid arthritis
39. Cardiovascular Medicine at the turn of the millennium: Triumphs, concerns and opportunities